Farapulse, Inc. clinical trials
Acquired by Boston Scientific Corporation, Aug 6, 2021 · source ↗
The registry lists 10 studies whose lead sponsor is Farapulse, Inc.. 0 are recruiting or about to start. Per ClinicalTrials.gov, last updated Jan 8, 2025.
Before and after it joined Boston Scientific Corporation
- First submitted before Farapulse, Inc. became part of Boston Scientific Corporation
- 7
- First submitted after Farapulse, Inc. became part of Boston Scientific Corporation
- 3
- Unclear, or no submission date
- 0
By the date each study was first submitted to the registry. The registry lists today's sponsor name and keeps no history, so this says when a study was filed, not who filed it.
Registry sponsor names on this page
- Farapulse, Inc.10 studies
Something wrong with this grouping? Tell us on the Boston Scientific Corporation page.
Studies
Recruiting first, then most recently updated. Showing 10 of 10. All Boston Scientific Corporation studies →
- The FARAPULSE PersAFOne III Trial for the Treatment of Persistent Atrial FibrillationCompletedNCT05272852Not applicable
Sponsor listed in the registry: Farapulse, Inc. · First submitted after Farapulse, Inc. became part of Boston Scientific Corporation
- The FARAPULSE ADVENT PIVOTAL Trial PFA System vs SOC Ablation for Paroxysmal Atrial FibrillationCompletedNCT04612244Not applicable
Sponsor listed in the registry: Farapulse, Inc. · First submitted before Farapulse, Inc. became part of Boston Scientific Corporation
- The FARAPULSE FARA-Freedom TrialCompletedNCT05072964Not applicable
Sponsor listed in the registry: Farapulse, Inc. · First submitted after Farapulse, Inc. became part of Boston Scientific Corporation
- Feasibility Study of the FARAPULSE™ Cardiac Ablation System Plus in the Treatment of Persistent Atrial Fibrillation(PersAFOne II)CompletedNCT05152966Not applicable
Sponsor listed in the registry: Farapulse, Inc. · First submitted after Farapulse, Inc. became part of Boston Scientific Corporation
- Feasibility Study of the FARAPULSE Endocardial Multi Ablation System in the Treatment of Persistent Atrial FibrillationCompletedNCT04170621Not applicable
Sponsor listed in the registry: Farapulse, Inc. · First submitted before Farapulse, Inc. became part of Boston Scientific Corporation
- A Single Arm Pilot Study of Pulsed Field Ablation in the Treatment of Paroxysmal Atrial FibrillationCompletedNCT04474054Not applicable
Sponsor listed in the registry: Farapulse, Inc. · First submitted before Farapulse, Inc. became part of Boston Scientific Corporation
- PEFCATII Expanded Safety and Feasibility Study of the FARAPULSE Endocardial Multi Ablation System to Treat Paroxysmal Atrial FibrillationCompletedNCT04170608Not applicable
Sponsor listed in the registry: Farapulse, Inc. · First submitted before Farapulse, Inc. became part of Boston Scientific Corporation
- A Safety and Feasibility Study of the FARAPULSE Endocardial Ablation System to Treat Paroxysmal Atrial FibrillationCompletedNCT03714178Not applicable
Sponsor listed in the registry: Farapulse, Inc. · First submitted before Farapulse, Inc. became part of Boston Scientific Corporation
- IMPACT: A Safety and Feasibility Study of the IOWA Approach Cardiac Ablation SystemCompletedNCT03700372
Sponsor listed in the registry: Farapulse, Inc. · First submitted before Farapulse, Inc. became part of Boston Scientific Corporation
- IMPULSE: A Safety and Feasibility Study of the IOWA Approach Endocardial Ablation System to Treat Atrial FibrillationCompletedNCT03700385Not applicable
Sponsor listed in the registry: Farapulse, Inc. · First submitted before Farapulse, Inc. became part of Boston Scientific Corporation